![Raffy Kazandjian](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Raffy Kazandjian
Directeur/Membre du Conseil chez
GENOWAY
Profil
Raffy Kazandjian is currently the Director at genOway SA, Venture Partner at Equitis Gestion SAS, Manager at Euromedical Instruments SARL, and Managing Partner at Unicorn Bio Tutors.
Previously, he held positions as Chairman at Meiogenix SAS, Director at Cellectis SA, Director at Oralance Pharma SA, Director at Eyevensys SAS, and Partner at Innovation Capital SASU.
From 1996 to 2002, he served as the President of CDC Innovation Partners.
Mr. Kazandjian obtained a graduate degree from the Massachusetts Institute of Technology in 1985, an MBA from INSEAD in 1990, and an undergraduate degree from École Nationale Supérieure de Chimie de Paris in 1983.
Postes actifs de Raffy Kazandjian
| Sociétés | Poste | Début |
|---|---|---|
| GENOWAY | Directeur/Membre du Conseil | - |
Equitis Gestion SAS
 Equitis Gestion SAS Investment ManagersFinance Equitis is a private equity investment manager investing in seed capital, start-up and expansion financing as a minority shareholder, in France and Europe. The firm is also active in the secondary market, and acquires minority participations, entire portfolios or private equity firms with a view to realizing assets. Equitis specializes in situations such as turnaround, liquidations, and the purchase of assets which are dormant or heavily written-down in value. They reorganize portfolios to improve liquidity and value. Liquidations are handled through the firm's wholly-owned subsidiary Infinitis. Equitis identifies assets with potential and actively manages them to unlock value. They contribute strategic advisory, management expertise, restructuration guidance and capital. They assume operational management when needed. | Analyste en capital-investissement | - |
Euromedical Instruments SARL
 Euromedical Instruments SARL Wholesale DistributorsDistribution Services Distributes radio-guided surgical sensors for surgeons and nuclear doctors | Corporate Officer/Principal | - |
Anciens postes connus de Raffy Kazandjian
| Sociétés | Poste | Fin |
|---|---|---|
CDC Innovation Partners
 CDC Innovation Partners Investment Trusts/Mutual FundsMiscellaneous Provides venture capital funding | President | 01/07/2002 |
Eyevensys SAS
 Eyevensys SAS Miscellaneous Commercial ServicesCommercial Services Develops non-viral gene therapy process for the treatment of ocular illnesses | Directeur/Membre du Conseil | - |
Innovation Capital SASU
 Innovation Capital SASU Investment ManagersFinance Innovation Capital is an active manager which specializes in technology venture capital, investing in both early- and late-stage businesses with distinctive technology and high-growth potential, within the information technology and life sciences industries. They have invested in sectors including information and communication technologies, clean technologies, advanced materials, robotics, healthcare, biotechnologies and medical technologies. The firm seeks to invest in companies with a dynamic management team with execution capacity, a sizeable growth market, immediate user relevance, competitive advantages, reasonable development cost, intellectual property potential, and a sustainable business model. Innovation Capital aims to foster the growth of their investee companies through advisory consulting and networking opportunities. They lead the first and subsequent financing round or co-invest in re-financing rounds. They follow a pragmatic investment approach, are actively involved in the management of their investee companies and seek board representation. | Corporate Officer/Principal | - |
Meiogenix SAS
 Meiogenix SAS BiotechnologyHealth Technology Operates as a biotech company which develops breeding technologies | Président | - |
Oralance Pharma SA
 Oralance Pharma SA Pharmaceuticals: MajorHealth Technology Designs and develops oral forms of drug molecules | Directeur/Membre du Conseil | - |
Formation de Raffy Kazandjian
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
89
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
CDC Innovation Partners
CDC Innovation Partners Investment Trusts/Mutual FundsMiscellaneous Provides venture capital funding | Miscellaneous |
Innovation Capital SASU
Innovation Capital SASU Investment ManagersFinance Innovation Capital is an active manager which specializes in technology venture capital, investing in both early- and late-stage businesses with distinctive technology and high-growth potential, within the information technology and life sciences industries. They have invested in sectors including information and communication technologies, clean technologies, advanced materials, robotics, healthcare, biotechnologies and medical technologies. The firm seeks to invest in companies with a dynamic management team with execution capacity, a sizeable growth market, immediate user relevance, competitive advantages, reasonable development cost, intellectual property potential, and a sustainable business model. Innovation Capital aims to foster the growth of their investee companies through advisory consulting and networking opportunities. They lead the first and subsequent financing round or co-invest in re-financing rounds. They follow a pragmatic investment approach, are actively involved in the management of their investee companies and seek board representation. | Finance |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
genOway SA
 genOway SA BiotechnologyHealth Technology Develops gene technology | Health Technology |
INSEAD
 INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cellectis SA
 Cellectis SA Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops immunotherapies | Health Technology |
Oralance Pharma SA
Oralance Pharma SA Pharmaceuticals: MajorHealth Technology Designs and develops oral forms of drug molecules | Health Technology |
Equitis Gestion SAS
Equitis Gestion SAS Investment ManagersFinance Equitis is a private equity investment manager investing in seed capital, start-up and expansion financing as a minority shareholder, in France and Europe. The firm is also active in the secondary market, and acquires minority participations, entire portfolios or private equity firms with a view to realizing assets. Equitis specializes in situations such as turnaround, liquidations, and the purchase of assets which are dormant or heavily written-down in value. They reorganize portfolios to improve liquidity and value. Liquidations are handled through the firm's wholly-owned subsidiary Infinitis. Equitis identifies assets with potential and actively manages them to unlock value. They contribute strategic advisory, management expertise, restructuration guidance and capital. They assume operational management when needed. | Finance |
Meiogenix SAS
Meiogenix SAS BiotechnologyHealth Technology Operates as a biotech company which develops breeding technologies | Health Technology |
Eyevensys SAS
Eyevensys SAS Miscellaneous Commercial ServicesCommercial Services Develops non-viral gene therapy process for the treatment of ocular illnesses | Commercial Services |
Euromedical Instruments SARL
Euromedical Instruments SARL Wholesale DistributorsDistribution Services Distributes radio-guided surgical sensors for surgeons and nuclear doctors | Distribution Services |
École Nationale Supérieure de Chimie de Paris
 École Nationale Supérieure de Chimie de Paris Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
